Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

Regeneron is building a $2 billion production facility in Saratoga Springs that will allow the Tarrytown drugmaker to double ...

In May, Jonathan Polkes ’84 secured a blockbuster $460.8 million jury verdict as lead counsel for Regeneron Pharmaceuticals ...

Regeneron’s Adam Gastonguay shares how to raise the profile of your IP team, get the most from outside counsel, and stay ahead of the growing pressure to adopt AI. If you don't have a login or your ...

A live webcast of the presentation will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with ...

THURSDAY, Nov. 13, 2025 (HealthDay News) — A new pill from Merck could change how millions of people treat high cholesterol ...

Regeneron stock increased by 19% over the past month, driven by strong third-quarter earnings. But is Gilead the better pick?

Pharmaceuticals announced new and updated data from its hematology portfolio and pipeline will be shared across 14 abstracts at ...

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 194 % ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this ...